Clinical significance of HER2 in urothelial carcinoma and analysis of its correlation with glycolytic metabolic characteristics

Clinical significance of HER2 in urothelial carcinoma and analysis of its correlation with glycolytic metabolic characteristics

ObjectiveThis study aimed to explore the clinical relevance of Human Epidermal Growth Factor Receptor 2 (HER2) in urothelial carcinoma (UC) and its association with glycolytic metabolic markers, insulin resistance, and beta-cell function, shedding light on potential therapies targeting both HER2 pat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Andong Guo, Chenrui Wu, Jishuang Cao, Kejia Zhu, Sentai Ding
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Molecular Biosciences
Subjects:	urothelial carcinoma HER2 glycolytic metabolism lactate dehydrogenase therapeutic targets
Online Access:	https://www.frontiersin.org/articles/10.3389/fmolb.2024.1521889/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Evaluation of CD10 and HER2 Immunohistochemical Markers in Urothelial Carcinoma of Urinary Bladder
by: Khalid W. Abdulfattah Khattab, et al.
Published: (2024-12-01)

FTO effects the proliferation, invasion, and glycolytic metabolism of colon cancer by regulating PKM2
by: Kongyan Zhang, et al.
Published: (2025-01-01)

Targeting glycolysis: exploring a new frontier in glioblastoma therapy
by: Lu Yang, et al.
Published: (2025-01-01)

Correlation of HER2 expression and clinicopathological characteristics in patients with urothelial carcinoma in China
by: WANG Shanshan, YE Dingwei, YANG Li, CHENG Fan, YANG Tiejun, ZHANG Xiaoping, YU Zhixian, ZHANG Qingyun, YANG Yong
Published: (2024-11-01)

Association between sex steroid hormones and α-klotho: Results from the NHANES 2013-2016 and Mendelian randomization study
by: Andong Guo, et al.
Published: (2025-03-01)

Ucp1 Ablation Improves Skeletal Muscle Glycolytic Function in Aging Mice
by: Jin Qiu, et al.
Published: (2025-01-01)

Glucose‐induced LINC01419 reprograms the glycolytic pathway by recruiting YBX1 to enhance PDK1 mRNA stability in hepatocellular carcinoma
by: Yanfang Liu, et al.
Published: (2024-12-01)

Plasmacytoid urothelial carcinoma with duodenal metastasis—A rare tumor with unusual site of metastasis with grim outcome
by: Aparna Chenniappan, et al.
Published: (2023-01-01)

Sulfatase modifying factor 2 as a predictive biomarker for urothelial carcinoma
by: Wei-Ting Kuo, et al.
Published: (2025-02-01)

Repurposing of Metformin to Improve Survival Outcomes in Patients With Upper Tract Urothelial Carcinoma
by: Hsiang Ying Lee, et al.
Published: (2025-01-01)

Efficacy and safety of selective pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors in FGFR-altered urothelial carcinoma
by: Yuxuan Song, et al.
Published: (2025-01-01)

Dramatic Response to Enfortumab Vedotin in Soft-tissue Metastases from Urothelial Carcinoma: A Case Report
by: Ming-Hsuan Wu, et al.
Published: (2024-12-01)

Neratinib and the Role of Anti‐HER2 Therapy in Salivary Duct Carcinoma
by: Martina Napolitano, et al.
Published: (2025-01-01)

Pathological features and immunohistochemical characteristics of clear cell (glycogen-rich) urothelial carcinoma: a case report and systematic review of the literature
by: Weiming Wang, et al.
Published: (2025-02-01)

Reduced p63 expression is linked to unfavourable prognosis in muscle‐invasive urothelial carcinoma of the bladder
by: Kira Furlano, et al.
Published: (2024-11-01)

Comparison of fluorescence in situ hybridization (FISH) and urine cytology in diagnosing urothelial carcinoma: a single-center retrospective cohort study
by: WANG Zhiting, et al.
Published: (2024-12-01)

Preliminary study on the diagnostic value of urine cell glucose metabolism detection for male urothelial carcinoma
by: Yaoyao Wu, et al.
Published: (2024-12-01)

Invasive micropapillary urothelial carcinoma of the renal pelvis presenting as nonfunctional kidney: A unique presentation and review of the literature
by: Mohammed Shahin, et al.
Published: (2024-12-01)

Predictive role of ABC transporters in the efficacy of enfortumab vedotin for urothelial carcinoma
by: Toshiki Kijima, et al.
Published: (2025-01-01)

The association of BMI and subclinical myocardial dysfunction in breast cancer patients after single or dual anti-HER2 targeted therapy
by: Feng Zhang, et al.
Published: (2024-12-01)

Novel combination therapy for platinum-eligible patients with locally advanced or metastatic urothelial carcinoma: a systematic review and network meta-analysis
by: Takafumi Yanagisawa, et al.
Published: (2025-02-01)

Programmed cell death 1 inhibitor alone or combined with chemotherapy for patients with locally advanced or metastatic urothelial carcinoma: a single-center experience
by: Xing Huang, et al.
Published: (2024-12-01)

New Trends and Future Perspectives in the Diagnosis of Urothelial Carcinoma: A Comprehensive Review of the Literature
by: Mourmouris Panagiotis, et al.
Published: (2025-01-01)

Performance of ChatGPT in providing patient information about upper tract urothelial carcinoma
by: Jan Łaszkiewicz, et al.
Published: (2024-07-01)

The Predictive Value of Lactate Dehydrogenase for Viral Suppression in Newly Diagnosed People Living With HIV on Antiretroviral Therapy: A Retrospective Cohort Study
by: Jin Y, et al.
Published: (2025-01-01)

Association between lactate dehydrogenase levels and all-cause mortality in ICU patients with heart failure: a retrospective analysis of the MIMIC-IV database
by: Panxu Guo, et al.
Published: (2025-01-01)

Review of the clinical status of cardiotoxicity of HER-2 positive breast cancer targeted therapeutic drugs
by: Xiang Zhang, et al.
Published: (2025-02-01)

Super-enhancers in hepatocellular carcinoma: regulatory mechanism and therapeutic targets
by: Xuejin Lu, et al.
Published: (2025-01-01)

The role of the interplay between macrophage glycolytic reprogramming and NLRP3 inflammasome activation in acute lung injury/acute respiratory distress syndrome
by: Lan Luo, et al.
Published: (2024-12-01)

Factors influencing salivary lactate dehydrogenase levels in oral squamous cell carcinoma and oral potentially malignant disorders
by: Rosa María López-Pintor, et al.
Published: (2025-01-01)

Expression of EZH2 and H3K27me3 predicts tumor biology of urothelial carcinoma
by: Rasheeda Mohamedali, et al.
Published: (2023-07-01)

Distribution and clinicopathological characteristics of G-CSF expression in tumor cells and stromal cells in upper tract urothelial carcinoma
by: Go Kobayashi, et al.
Published: (2024-12-01)

Using apparent diffusion coefficient maps and radiomics to predict pathological grade in upper urinary tract urothelial carcinoma
by: Rile Nai, et al.
Published: (2024-12-01)

Target trial emulation to evaluate the effect of immune-related adverse events on outcomes in metastatic urothelial cancer
by: Renate Pichler, et al.
Published: (2024-12-01)

Cost-effective whole-cell biosynthesis of ursodeoxycholic acid using engineered Escherichia coli with a multienzyme cascade
by: Xue Zhang, et al.
Published: (2025-01-01)

The predictive value of the serum creatinine-to-albumin ratio (sCAR) and lactate dehydrogenase-to-albumin ratio (LAR) in sepsis-related persistent severe acute kidney injury
by: Xiaoxiao Luo, et al.
Published: (2025-01-01)

A Multi-ingredient Supplement Reduced Markers of Muscle Damage after a Rugby Match in Collegiate Male Players
by: Chang-Li Hsueh, et al.
Published: (2024-12-01)

Specific Activity of Lactate Dehydrogenase in Muscle and Liver Tissues of Rats Exposed to Intermittent Hypobaric Hypoxia
by: Syarifah Dewi, et al.
Published: (2025-01-01)

Effectiveness and safety of PD-1/L1 inhibitors as first-line therapy for patients with advanced or metastatic urothelial carcinoma who are ineligible for platinum-based chemotherapy: a meta-analysis
by: Weiming Liang, et al.
Published: (2025-02-01)

Papillary urothelial neoplasm of low malignant potential with osseous metaplasia in a 19-year-old chronic smoker: A case report with review of literature
by: Rakesh K. Gupta, et al.
Published: (2022-05-01)